'Brown fat' may be a key to curing obesity
By manipulating levels of the protein BMP-7, Harvard Medical School researchers were able to generate a larger store of "brown" fat cells that burn calories--a pathway that could be used to pursue new therapies to fight obesity and a range of metabolic diseases. Mice injected with the protein reportedly developed more of the brown fat tissue and gained less weight.
It turns out that there are two kinds of fat: Brown and white. Brown fat is more prevalent in infants and has a key role to play in metabolism. And it is generated by the same precursor cells that produce muscle. In a separate study, researchers identified a "master regulator" protein--PRDM16--that pushes the cells to develop along different paths.
"I think we now have very convincing evidence that PRDM16 can turn cells into brown fat cells, with the possibility of combating obesity," says Bruce Spiegelman of the Dana Farber Cancer Institute.
- read the story from AFP
Related Articles:
Obesity drugs pose weighty problems for researchers
LRPR1: A new target for obesity, diabetes
Common virus is a culprit in obesity
Molecular research points to new obesity therapy
Fat cell research points to new approach on obesity
Comments
These findings are interesting to me in that it begs the question: Are these proteins which increase the calorie burning "brown fat" cells increased by natural means such as excercise? Indeed the obesity problem has gotten out of hand and certainly appears to warrant pharmacological manipulation. However, I would like to understand how nature exerts its influence with these proteins BMP-7 and PRDM16. This way, specific exercise or dietary means may be prescribed as well to augment the process.
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


